Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
T Cell Activation
100%
Negative Regulation
100%
Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4)
100%
Anticytotoxic
100%
Melanoma
33%
Immune System
22%
Adverse Events
22%
Objective Response
22%
T Cell Response
22%
CD28
22%
Therapeutic Monoclonal Antibody
22%
Immune Response
11%
Melanoma Patients
11%
Gastrointestinal Tract
11%
T Cells
11%
Mechanism of Action
11%
Monoclonal Antibody
11%
Survival Rate
11%
CD8+
11%
Autoimmune Response
11%
Clinical Data
11%
Preclinical Data
11%
Systems-based
11%
CD4+
11%
Self-tolerance
11%
Effector Cells
11%
Gastrointestinal Toxicity
11%
Adverse Reactions
11%
Immune Activation
11%
Cell Toxicity
11%
Direct Activation
11%
Immune Tolerance
11%
Inhibitory Signaling
11%
Melanocytes
11%
Good Target
11%
Antitumor T Cells
11%
Modulatory Signals
11%
Immune Effector Cell-associated Neurotoxicity Syndrome (ICANS)
11%
Enterocolitis
11%
Immunology and Microbiology
T Cell Activation
100%
CTLA-4
100%
T Cell
33%
CD28
22%
Monoclonal Antibody Therapy
22%
Immune System
22%
Immune Response
11%
CD8
11%
Monoclonal Antibody
11%
Survival Rate
11%
Autoimmunity
11%
CD4
11%
Immune Tolerance
11%
Effector Cell
11%
Gastrointestinal Tract
11%
Enterocolitis
11%
Melanocyte
11%